This technology is a cyclopropenium polymer-based system that can be loaded with a biomolecule cargo for efficient delivery to cells.
Current cell delivery systems rely on various methods to deliver the genetic material to the cell. One such method involves the use of viruses as delivery vehicles, which can be disadvantageous due to toxicity, the production of inflammatory responses, and their difficulty with delivering large DNA fragments. Polymers provide a potential virus-free alternative for encapsulating biomolecules to prevent their degradation before reaching the desired target. Unfortunately, currently available polymers are not stable at physiological pH levels, are limited in size, and are difficult to synthesize.
This technology uses cyclopropenium-based polymer complexes for the delivery of biomolecules to cells. The synthesized cyclopropenium polymer nanoparticles have a positive charge that is maintained over a wide range of pH levels, including physiological pH, and covers a wide range of sizes. These polymers do not include a cytotoxic amine group and do not require additional emulsifiers. Additionally, cargo can be loaded into the interior of these particles prior to polymerization and targeting moieties can be added post polymerization for improved targeting and delivery of biomolecules. As a result, this technology is effective in a wide range of fields including, gene delivery, drug delivery, diagnostics, and therapeutics.
This technology has been validated in vitro by measuring gene transfection efficiency.
Patent Pending (WO/2018/035435)
Patent Pending (US 20170226246)
IR CU15012, CU15294, CU16329, CU18061
Licensing Contact: Cynthia Lang